Blog

14 Aug 2018

Analysis Tesla IP chief jumps to automotive rival

Jeff Risher has left his post as Tesla’s head of IP to join rival electric car manufacturer Faraday Future as vice president, technology and IP. According to his LinkedIn profile he joined Faraday last month after a little more than two years at Tesla where he was chief IP and litigation counsel. Prior to that he spent almost a decade at Apple, most recently as director of patent licensing and strategy.  The fact that Faraday has hired such an experienced IP executive suggests Read more

Richard Lloyd

14 Aug 2018

Analysis CJEU’s failure to clear up SPC mess highlights difficulties with non-specialist judges

Pharmaceuticals rights holders waited anxiously for the Court of Justice for the European Union’s (CJEU’s) judgment regarding the dispute over the validity of Gilead’s supplementary protection certificate (SPC) for Truvada. It was a decision that many hoped would clear up significant legal confusion surrounding the conditions under which SPC rights can be granted. However, the ruling recently issued by Europe’s highest court seems to have raised as many questions as Read more

Adam Houldsworth

13 Aug 2018

Analysis ETRI exclusive licence deals signal two new campaigns to monetise its US patent holdings

South Korea’s Electronics and Telecommunications Research Institute (ETRI) looks to have gotten a pair of monetisation efforts off the ground over the past couple of weeks. The new initiatives come over a year after a previous campaign was brought to an end with an unfavourable ruling on standing. On the final day of July, an entity called Sequoia Technology, LLC filed infringement complaints in the Federal District of Delaware targeting Dell, Hewlett Packard Enterprise and Hitachi. Read more

Jacob Schindler

10 Aug 2018

Analysis IV assignments to Native American tribe shows just how far it is casting sales net

This blog has closely followed the patent divestments that Intellectual Ventures has undertaken since the firm stopped buying for its most recent fund and looked to slim down its giant portfolio. Many of those assets have ended up in familiar hands, with Dominion Harbor picking up the lion’s share and others going to entities linked to serial patent monetiser Leigh Rothschild.  However, two recent assignments (seen here and here) recorded with the USPTO show the range of acquirers Read more

Richard Lloyd

10 Aug 2018

Analysis Microsoft leads in machine learning with Alphabet in hot pursuit – but the field remains wide open

Microsoft and Alphabet currently own the most – and the highest quality – patents relating to machine learning, research commissioned by IAM has revealed. However, the data also shows that most companies are being outpaced by the technology’s rapid rate of development, and at this stage anyone could come from anywhere to claim a leadership position. Jointly produced by IP analytics platform PatentSight and ip-search, a commercial patent search service provider of the Swiss Read more

Timothy Au

09 Aug 2018

News US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis patents from inter partes review, the new bill seeking to roll out compulsory licensing in the US, and the Indian Supreme Court’s hearing on seed patentability. Market Radar Compulsory licensing bill attracts support in the US – A proposed legislative amendment that among other things seeksto allow compulsory licences Read more

Adam Houldsworth

09 Aug 2018

Analysis JPO commissioner will stay at the reins as her signature ADR initiative gets off the ground

Japan Patent Office commissioner Naoko Munakata will stay on the job for a second year, IAM understands. After a year spearheading initiatives around SEP policy, we will see whether the JPO’s focus shifts or stays in the same place. Munakata took over the top job from Yoshinori Komiya in July 2017, becoming the first woman ever to serve in the role. Senior bureaucrats typically stay at the helm of the JPO for only one or two years. Over the past ten years, just two of eight Read more

Bing Zhao

08 Aug 2018

News Just a week after the US mid-term elections, the 4th Patent Law and Policy event couldn't be more timely

IAM is returning to Washington DC in November for our fourth annual Patent Law and Policy event. Two years since the election of President Trump, the conference will provide the perfect opportunity to hear from the major IP players inside the Beltway on how the administration is re-shaping the US patent narrative. The event will also be one week after this year’s mid-term elections and while much of the media attention will rightly be on whether Democrats can regain control of either Read more

Joff Wild

07 Aug 2018

Analysis With possible $400 million licensing opportunity in sight, Finjan brings in bank to weigh up strategic options

There was little surprise in the numbers that Finjan recently announced for the second quarter. Revenue for the first half of the year soared to $82.3 million, an increase of more than 200% year-on-year. This was thanks in large part to the company’s settlement with Symantec, but also helped by additional agreements with Carbon Black and Trend Micro. Net income for the half year also saw a correspondingly large jump to $36.3 million, an increase of almost 177% as the business generated Read more

Richard Lloyd

07 Aug 2018

Analysis Why Chinese biotech inventions have yet to make an impact globally, despite patenting surge

A new academic article about patenting in the BRICS countries makes fascinating reading for life sciences IP professionals interested in gauging the development and current state of China’s biotechnology patent landscape. On the one hand, it highlights the drastic increases achieved in the number of biotech patent applications made by China-based innovators over recent years – a surge that far exceeds that in other emerging economies. But, on the other hand, the study casts Read more

Adam Houldsworth

Close

Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 91